Methods for Stratification and Validation Cohorts: A Scoping Review

Fecha de publicación

2023-01-17T17:24:31Z

2023-01-17T17:24:31Z

2022-04-26

2023-01-17T17:24:31Z

Resumen

Personalized medicine requires large cohorts for patient stratification and validation of patient clustering. However, standards and harmonized practices on the methods and tools to be used for the design and management of cohorts in personalized medicine remain to be defined. This study aims to describe the current state-of-the-art in this area. A scoping review was conducted searching in PubMed, EMBASE, Web of Science, Psycinfo and Cochrane Library for reviews about tools and methods related to cohorts used in personalized medicine. The search focused on cancer, stroke and Alzheimer's disease and was limited to reports in English, French, German, Italian and Spanish published from 2005 to April 2020. The screening process was reported through a PRISMA flowchart. Fifty reviews were included, mostly including information about how data were generated (25/50) and about tools used for data management and analysis (24/50). No direct information was found about the quality of data and the requirements to monitor associated clinical data. A scarcity of information and standards was found in specific areas such as sample size calculation. With this information, comprehensive guidelines could be developed in the future to improve the reproducibility and robustness in the design and management of cohorts in personalized medicine studies.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

MDPI

Documentos relacionados

Reproducció del document publicat a: https://doi.org/10.3390/jpm12050688

Journal of Personalized Medicine, 2022, vol. 12, num. 5, p. 688

https://doi.org/10.3390/jpm12050688

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

cc-by (c) Torres Moral, Teresa et al., 2022

https://creativecommons.org/licenses/by/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)